France IVD Market Expected to Reach $4,509 million by 2023

According to a new report published by Allied Market Research, titled, "France IVD Market by Product Type, Techniques, Application and End-Users: Global Opportunity Analysis and Industry Forecast, 2017-2023.",France IVD market was valued at $2,943 million in 2016, and is projected to reach at $4,509 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023.

Access Full Summary at: https://www.alliedmarketresearch.com/france-IVD-market

In vitro diagnostics (IVD) technique includes medical devices and reagents, utilized for the examination of biological specimen such as, blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. In addition, IVD tests are employed in stand-alone laboratory, and hospital based laboratory. Techniques such as, polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry are used for analysis of biological samples.

Based on product types, the reagents segment held the highest market share in 2016, due to R&D in chemical science and invention of new chemical reagents for IVD technique.

Based on techniques, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of carcinogenic disease.

Based on application, the infectious diseases segment contributed the highest market share in 2016, due to rapid increase in infectious diseases and rise in awareness about health.

Based on end users, in 2016, the standalone laboratory segment captured the highest market share. This is mainly attributed to the fact that standalone laboratories are well equipped with high-tech infrastructure to perform difficult IVD tests with high precision over hospitals.

Key Findings of the France IVD Market

• The immunodiagnostics segment dominated the market in 2016, and is projected to grow at the 6.4% CAGR.
• The immunodiagnostics segment accounted for the highest share in 2016.
• The standalone laboratory segment accounted for the highest share in 2016.
• France is expected to grow at the highest CAGR in the IVD market.

The major players profiled in the France IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson.